HEPATOMEGALY

Clinical trials for HEPATOMEGALY explained in plain language.

Never miss a new study

Get alerted when new HEPATOMEGALY trials appear

Sign up with your email to follow new studies for HEPATOMEGALY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Completed 1

New hope for rare blood disorder: drug targets overactive immune cells

Disease control Recruiting now

This phase 2 trial is testing the drug ruxolitinib in people with hypereosinophilic syndrome, a rare condition where the body produces too many eosinophils (a type of white blood cell), causing organ damage. The study aims to see if ruxolitinib can normalize blood cell counts and…

Matched conditions: HEPATOMEGALY

Phase: PHASE2 • Sponsor: William Shomali • Aim: Disease control

Last updated Jun 27, 2026 08:06 UTC

HEPATOMEGALY

Get alerted when new HEPATOMEGALY trials appear

New hope for rare blood disorder: drug targets overactive immune cells